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ABSTRACT
The identification and study of evolutionarily con-
served genomic sequences that surround disease-
related genes is a valuable tool to gain insight into
the functional role of these genes and to better eluci-
date the pathogenetic mechanisms of disease. We
created the DG-CST (Disease Gene Conserved
Sequence Tags) database for the identification and
detailed annotation of human–mouse conserved
genomic sequences that are localized within or in the
vicinity of human disease-related genes. CSTs are
defined as sequences that show at least 70% identity
between human and mouse over a length of at
least 100 bp. The database contains CST data relative
to over 1088 genes responsible for monogenetic
human genetic diseases or involved in the suscept-
ibility to multifactorial/polygenic diseases. DG-CST
is accessible via the internet at http://dgcst.ceinge.
unina.it/ and may be searched using both simple
and complex queries. Agraphic browser allowsdirect
visualization of the CSTs and related annotations
within the context of the relative gene and its
transcripts.
INTRODUCTION
Alignment of DNA sequences from different species provides
an effective tool to decode genomic information, based on the
assumption that functional sequences tend to evolve at a
slower rate than non-functional sequences. The availability
of the complete genomic sequences from a variety of species
(1–4) allows to carry out these analyses very effectively and to
identify, besides coding sequences, also non-coding sequences
with either regulatory or structural functions (5–8).
A comparative analysis of the human and murine genomes
revealed the presence of a surprisingly high number of sequence
elements longer than 100 bp and displaying a sequence identity
>70% between human and mouse (6). Interestingly, more than
half of these conserved sequences do not represent known ele-
ments belonging to protein-coding genes and may therefore
represent non-coding RNAs, expression control elements or
chromosomal structural elements. Such sequences have been
previously termed CNG (conserved non-genic sequences)
(9,10) or CNS (conserved non-coding sequences) (2). Here,
we use the more neutral and descriptive expression ‘conserved
sequence tags’ (CST), which is appropriate also to describe
exons.
To gain further insight into the biological role of these con-
served sequences, we chose to identify and annotate CSTs
belonging to a set of human genes involved in the pathogenesis
of genetic diseases. These are among the best-studied human
genesas theyhavebeentheobjectsofverydetailedstructuraland
functional characterization in the past 15–20 years. Further-
more, novel functional elements within these genes may be
targets of yet unidentified mutations leading to genetic diseases.
Information on CSTs related to human disease genes can also be
gathered from reference genome sequence databases, i.e.
Ensembl (11) and Genome Browsers (12), or from more spe-
cialized resources, i.e. Vista Browser (13) and GALA (14).
However, these valuable resources are not specifically designed
for the study of human disease genes and retrieval of CST data
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for these genes may turn out to be difficult and statistical
analysis impossible since CSTs are not explicitly annotated.
Therefore, we decided to build DG-CST (Disease Gene
CST), a database of human–mouse conserved elements asso-
ciated to disease genes. To this purpose, systematic identifica-
tionofCSTsinhumandiseasegeneswascarriedout, followedby
detailed bioinformatic analysis, aimed at identifying novel
functional elements associated with these genes, either tran-
scribed and possibly coding sequences or non-transcribed
sequence elements with a hypothetical role in the control of
gene expression. The DG-CST database is available to the
scientific community through a Web interface at the address
http://dgcst.ceinge.unina.it/. The annotation of CSTs related
to disease genes will be valuable for the elucidation of the
functional role of these conserved sequences and for a
better understanding of the pathogenesis of human genetic
disorders.
CONSTRUCTION AND ORGANIZATION OF
THE DG-CST
Sequence acquisition and CST identification
A list of human genes involved in either the pathogenesis of
monogenic human disorders or in the predisposition to multi-
factorial diseases was obtained by screening the Genecards (15)
and the On-Line Mendelian Inheritance in Man (OMIM) (16)
databases. We then searched the human Ensembl database
(assembly release NCBI34) to retrieve the human genomic
sequences spanning the selected transcripts as well as 250 addi-
tionalkilobasesofflankingsequenceonbothsides.Theextentof
the flanking sequence was reduced when known genes were
annotated in proximity of the disease gene, but a minimum of
20 kb was taken in all cases. The Ensembl database was also
used as the source of the corresponding murine sequences.
Orthologous gene annotation was used, when available, to
find the mouse counterparts; when more than one orthologous
gene was found, sequences were manually selected, on the basis
of overall sequence conservation and relationships with other
neighboring sequences. Mouse sequence size was defined
according to the length of the human sequence.
A total set of 1088 human genomic sequences was com-
pared to the corresponding murine orthologous genomic
sequences (the full list is available online). Overall, 193 million
bp of human genomic sequences were analyzed, corres-
ponding to 7% of the human genome. Human and mouse
genomic sequences, prefiltered to mask all known repeated
sequences, were compared using the BLASTZ program (17).
Sequences showing at least 70% identity, over a region of at
least 100 bp, were selected and further analyzed to eliminate
redundancies, leading to the identification of 66 495 repeat-
free, non-overlapping, human and mouse CST pairs. The CSTs
were found to correspond or to overlap to known human exon
sequences in about 32% of cases (n = 21 139) while they were
located either in intronic or in intergenic region in the remain-
ing 68% of cases (n = 45 356) (Table 1).
CST annotation
The identified CSTs are collected in the DG-CST
database, together with a large number of annotations
including:
 species;
 genomic location, i.e. chromosome, position, relationship
with the closest gene and with the selected disease gene
(often coincident);
 sequence content, i.e. sequence, length, GC percentage;
 identity between human and mouse sequences, number of
gaps, polarity;
 BLAST matches with other CSTs, as well as with other
human genomic sequences;
 BLAST matches versus non-redundant nucleotide databases;
 conservation in other species, as assessed by BLAST analysis
versus the drafts of fugu (3), chicken (11), rat (4) and zebra-
fish (11) genome sequences;
 classification of CSTs in ‘intronic’, ‘intergenic’, ‘exonic’
based on Ensembl gene annotations;
 potential of CSTs of representing transcribed/coding ele-
ments based on a number of different tests, including deter-
mination of maximum ORF size, presence of putative splice
sites, exonic splicing enhancers (18), exon predictions based
on GENSCAN (19), BLAST matches with expressed
sequence tags (ESTs) and non-redundant protein databases,
word frequencies, determination of the coding potential score
(c.p.s.) according to the CSTMiner algorithm (20,21), a
recently developed software based on pairwise genome
comparison;
 presence of single nucleotide polymorphisms (SNPs), as
reported in Ensembl;
 presence of palindromes, tandem repeats, putative RNA
secondary structures as predicted by using the ddbRNA
software (22);
 presence of putative transcription factor (TF) binding sites, as
assessedusingBID,anewlydevelopedalgorithm(A.Ambesi,
M. Bansal and D. di Bernardo, unpublished data).
DATABASE SEARCH
The DG-CST database contains all the annotations and is
designed to allow easy retrieval of CST information. Search-
ing is supported in a number of different ways. A graphic
browser allows direct visualization of the CSTs, within the
context of the relative gene and its transcripts. Briefly, CST
information can be accessed in the following ways:
(i) By choosing from a list of all analyzed disease genes
available in the home page (Figure 1A and B).
(ii) By selecting one or more genes either as a quick search
option from the home page (Figure 1A, black box) or
following the ‘gene’ link. Gene selection may be carried
out by gene symbol, disease name and several other cri-
teria, also in combination (Figure 1E).
Table 1. Classification of human CSTs present in DG-CST
CST type Number % Length (bp) Length (%)
Exonic 21 139 31.8 5 247 362 34.9
Intronic 18 390 27.7 3 832 169 25.5
Intergenic 26 966 40.5 5 962 769 39.6
Total 66 495 100 15 042 300 100
D506 Nucleic Acids Research, 2005, Vol. 33, Database issue
 at U
niversity degli Studi M
ilano on February 21, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
(iii) By querying the database for CSTs selected according to a
large numberofannotated features, alone or incombination,
in the ‘Advanced’ section (Figure 1D). To facilitate the
search, reduced feature sets are available where CSTs
can be searched by (a) DNA-based features such as pre-
sence of tandem repeats, palindromes, SNPs (Figure 1C);
(b) RNA-based features such as presence of putative
secondary structures, matches with ESTs, GENSCAN
predicted exons; (c) protein-coding features, such as exon
annotation, coding potential, BLAST matches with pro-
teins; (d) CSTs localized to selected chromosomal regions.
(iv) Finally, CSTs can be searched by BLAST sequence ana-
lysis from the home page (Figure 1A, red box).
Each CST entry present in DG-CST is assigned a unique
identifier (CST ID) that can also be used to quickly find the
Figure 1. The DG-CST database: examples of query interfaces. (A) The DG-CST home page. The quick search boxes are highlighted in color: the CST ID box in
green; the gene box in black; and the BLAST box in red. (B) The list of all analyzed genes obtained following the link on the home page. (C) The DNA-based feature
search page. (D) The advanced CST search page, where all annotated features may be used in combination or alone to query the database. (E) The gene-based CST
search page, which allows a more detailed gene search.
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CST from different sections of the database, including the
home page.
DATA DISPLAY
When searching DG-CST using the previously described
‘DNA-based’, ‘RNA-based’, ‘protein-based’, ‘advanced’
and ‘localization’ features, a list of CST entries that meet
the search criteria can be accessed. Individual CSTs may be
visualized in a specific page where all annotations available on
that particular CST are displayed (Figure 2C). Matching CSTs
from other species may be seen and compared in a multi-
sequence alignment (Figure 2D). Matches found for each
CST in a number of BLAST searches, pre-run against collec-
tions of genomic, EST or protein databases, may also be dis-
played starting from the CST page.
Figure 2. The DG-CST database: data display. (A) Example of a gene entry (A2M) and the related CST list. (B) Graphical representation of the selected gene,
accessible via the map link in (A). On mouse over, details of CST #250083 are displayed as an example. In this representation, CSTs are color-coded based on the
number of matches with human ESTs. (C) Example of a CST entry with all annotations and the list of the corresponding CSTs conserved in other species. CST details
are accessible either from the CST list of the gene page (A) or by clicking on the interactive graphical browser in (B). (D) Graphical representation of the sequence
alignment of the orthologous CSTs shown in (C).
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On the other hand, when searching by gene/disease name
and/or symbol, it is possible to obtain a list of gene entries that
meet the search criteria. Each gene entry, in addition to links to
external resources such as LocusLink, ENSEMBL and OMIM,
provides a ‘CST list’ link that gives access to the list of all
CSTs found by analyzing the selected disease gene region, as
shown in Figure 2A. By clicking on each entry, it is possible to
access all the data pertaining to a given human CST, as
described above.
Graphical representation is accessible through a ‘map’ link,
where CSTs and related annotations are shown within the
context of the relative gene and its transcripts (Figure 2B).
Moving through the genomic region and zooming to various
levels of detail are supported. CSTs may be labeled by a color
code on the basis of several quantitative parameters such as
degree of human–mouse sequence identity, GC content, num-
ber of gaps, putative RNA secondary structures, palindromes
and tandem repeats. To avoid an exceedingly crowded map,
the graphic visualization tool allows the user to display
selected CST subsets, such as:
(i) intergenic, intronic or exonic CSTs;
(ii) CSTs containing putative TF binding sites;
(iii) CSTs with matches to ESTs;
(iv) CSTs conserved in additional species, besides human and
mouse, such as chicken, fugu, zebrafish. These CSTs have
a higher probability of representing functional elements
playing a basic role in vertebrates as suggested by recent
reports (23).
CONCLUSIONS
DG-CST is an annotated collection of conserved sequences
related to genes involved in genetic diseases and may represent
a valuable resource for investigators interested in studying the
molecular mechanisms that underlie genetic diseases. The
database will be updated on a regular basis to include informa-
tion on newly identified human disease genes as well as on
new genomic data (e.g. sequences from additional organisms).
DG-CST may help in deciphering the spectrum of pathoge-
netic mutations that determine genetic diseases. Mutations are
usually searched for in the coding regions of a gene, but
may easily occur in other areas. CSTs provide a vast library
of putative novel functional sites, such as non-previously
described exons and/or elements possibly playing a role in
regulating the level of gene expressions, which may be func-
tionally tested as well as screened for mutations in patients,
particularly in diseases where the analysis of the known func-
tional elements of the disease gene failed so far in identifying a
relevant number of causative mutations (24–27). There are a
number of evidences that point to the direct involvement of
regulatory control elements in the pathogenesis of human dis-
orders, both due to chromosomal rearrangements (28,29) and
to point mutations (30–32). However, the recognition of patho-
genic mutations leading to genetic disorders in regulatory
elements has been so far hampered by our limited knowledge
of the structure and function of the elements associated to
disease genes. The availability of the DG-CST database should
be a valuable resource in order to fill this gap of information
and to facilitate the efforts aimed at both elucidating the
function of disease genes and at better understanding the
pathogenetic mechanisms of genetic diseases.
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